SCHEMBL6533044

SCHEMBL6533044

COC(=O)Oc1ccc2c(c1)nc(NCc1ccccn1)n2C1CCCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 3/20 0.46
GAA P10253 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
GFER P55789 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TRPC5 Q9UL62 1/20 0.41
OPRM1 P35372 2/20 0.41
OPRD1 P41143 2/20 0.41
OPRK1 P41145 2/20 0.41
OPRL1 P41146 2/20 0.41
OGFRL1 Q5TC84 2/20 0.41
SUMO3 P55854 1/20 0.40
SUMO2 P61956 1/20 0.40
SUMO1 P63165 1/20 0.40
RAF1 P04049 1/20 0.40
BRAF P15056 1/20 0.40
HPGD P15428 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6532520 0.91 ALDH1A1 (0.47) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL6527860 0.87 BRD4 (0.46) L3MBTL1OPRM1OPRD1OPRK1OPRL1
SCHEMBL6528391 0.85 OPRM1 (0.41) L3MBTL1OPRM1OPRD1OPRK1OPRL1
SCHEMBL6528355 0.85 IDH1 (0.41) ALDH1A1KDM4EGAAL3MBTL1OPRM1
SCHEMBL6528295 0.84 LMNA (0.44) GAANPC1RAB9AOPRM1OPRD1
SCHEMBL6532516 0.83 L3MBTL1 (0.55) ALDH1A1KDM4EGAANPC1RAB9A
SCHEMBL6532288 0.82 ACSL1 (0.41) L3MBTL1OPRM1OPRD1OPRK1OPRL1
SCHEMBL6530267 0.82 HDAC6 (0.46) L3MBTL1OPRM1OPRD1OPRK1OPRL1
SCHEMBL6531083 0.82 L3MBTL1 (0.39) L3MBTL1OPRM1OPRD1OPRK1OPRL1
SCHEMBL6529996 0.81 L3MBTL1 (0.40) L3MBTL1OPRM1OPRD1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005019186-A1 2-AMINOBENZIMIDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF HIV/AIDS BAYER HEALTHCARE AG (DE) 2005-03-03 WO disclosed